GE HealthCare Technologies Inc. reported its financial results for the fourth quarter and full year ended December 31, 2025. For the fourth quarter, net income attributable to shareholders was USD 589 million. For the full year 2025, net income attributable to shareholders was USD 2.08 billion, representing a 4.6 percent increase. Adjusted EBIT for the fourth quarter totaled USD 720 million, while full year adjusted EBIT reached USD 1.99 billion. Key performance indicators for the period included organic orders growth, which measures the rate of change in contractual commitments with customers for goods and services, and book-to-bill ratio, defined as total orders divided by total revenues for the given period. These metrics are used by management to provide insight into current business demand and overall revenue trends. GE HealthCare Technologies Inc. also highlighted the use of non-GAAP financial measures, such as organic revenue and organic revenue growth rate, to supplement GAAP results and provide additional understanding of underlying business performance. A webcast and accompanying slide presentation with further financial details are available on the company's investor relations website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260204794347) on February 04, 2026, and is solely responsible for the information contained therein.
Comments